Published in World J Gastroenterol on February 14, 2006
Endoplasmic reticulum stress inhibition protects steatotic and non-steatotic livers in partial hepatectomy under ischemia-reperfusion. Cell Death Dis (2010) 1.31
Hypoxia inducible factor-1alpha accumulation in steatotic liver preservation: role of nitric oxide. World J Gastroenterol (2010) 0.97
Attenuation of endoplasmic reticulum stress and mitochondrial injury in kidney with ischemic postconditioning application and trimetazidine treatment. J Biomed Sci (2012) 0.84
Emerging concepts in liver graft preservation. World J Gastroenterol (2015) 0.84
Insulin like growth factor-1 increases fatty liver preservation in IGL-1 solution. World J Gastroenterol (2010) 0.84
Sirtuin 1 in rat orthotopic liver transplantation: an IGL-1 preservation solution approach. World J Gastroenterol (2015) 0.77
GSK3β and VDAC Involvement in ER Stress and Apoptosis Modulation during Orthotopic Liver Transplantation. Int J Mol Sci (2017) 0.75
Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99
Mitochondrial abnormalities in non-alcoholic steatohepatitis. J Hepatol (1999) 1.81
Fatty liver in liver transplantation and surgery. Semin Liver Dis (2001) 1.79
Hepatic steatosis and its relationship to transplantation. Liver Transpl (2002) 1.78
Impairment of mitochondrial oxidative phosphorylation in rat fatty liver exposed to preservation-reperfusion injury. J Hepatol (2004) 1.67
Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation (1989) 1.58
Mechanisms of ischemic injury are different in the steatotic and normal rat liver. Hepatology (2000) 1.54
Ischemic-type biliary complications after orthotopic liver transplantation. Hepatology (1992) 1.46
Adenosine monophosphate-activated protein kinase mediates the protective effects of ischemic preconditioning on hepatic ischemia-reperfusion injury in the rat. Hepatology (2001) 1.43
Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver. Hepatology (1999) 1.33
Ischemic preconditioning increases the tolerance of Fatty liver to hepatic ischemia-reperfusion injury in the rat. Am J Pathol (2002) 1.32
The isolated perfused rat liver: conceptual and practical considerations. Hepatology (1986) 1.31
Hepatic microcirculatory changes after reperfusion in fatty and normal liver transplantation in the rat. Transplantation (1993) 1.18
Ischemic preconditioning protects the steatotic mouse liver against reperfusion injury: an ATP dependent mechanism. J Hepatol (2003) 1.13
The greater vulnerability of bile duct cells to reoxygenation injury than to anoxia. Implications for the pathogenesis of biliary strictures after liver transplantation. Transplantation (1993) 1.11
Ischemic preconditioning affects interleukin release in fatty livers of rats undergoing ischemia/reperfusion. Hepatology (2004) 1.11
The effects of N-acetylcysteine and anti-intercellular adhesion molecule-1 monoclonal antibody against ischemia-reperfusion injury of the rat steatotic liver produced by a choline-methionine-deficient diet. Hepatology (1997) 1.09
Effect of trimetazidine on membrane damage induced by oxygen free radicals in human red cells. Br J Clin Pharmacol (1985) 1.09
Primary nonfunction of fatty livers produced by alcohol is associated with a new, antioxidant-insensitive free radical species. Transplantation (1995) 1.05
Ischemic preconditioning: a defense mechanism against the reactive oxygen species generated after hepatic ischemia reperfusion. Transplantation (2002) 1.04
Attenuation of liver normothermic ischemia--reperfusion injury by preservation of mitochondrial functions with S-15176, a potent trimetazidine derivative. Biochem Pharmacol (2001) 1.02
Role of hepatocytes and bile duct cells in preservation-reperfusion injury of liver grafts. Liver Transpl (2001) 0.99
Effect of trimetazidine on mitochondrial function and oxidative damage during reperfusion of ischemic hypertrophied rat myocardium. Pharmacology (1993) 0.95
Cold preservation of fatty liver grafts: prevention of functional and ultrastructural impairments by venous oxygen persufflation. J Hepatol (2000) 0.93
Critical preservation injury in rat fatty liver is to hepatocytes, not sinusoidal lining cells. Transplantation (1998) 0.89
A preservation solution with polyethylene glycol and calcium: a possible multiorgan liquid. Transpl Int (2002) 0.88
High-Na+ low-K+ UW cold storage solution reduces reperfusion injuries of the rat liver graft. Transpl Int (1998) 0.88
Trimetazidine reduces renal dysfunction by limiting the cold ischemia/reperfusion injury in autotransplanted pig kidneys. J Am Soc Nephrol (2000) 0.88
Sinusoidal flow block after warm ischemia in rats with diet-induced fatty liver. J Surg Res (1997) 0.87
Protective roles of polyethylene glycol and trimetazidine against cold ischemia and reperfusion injuries of pig kidney graft. Am J Transplant (2004) 0.87
Effects of trimetazidine on lipid peroxidation and phosphorus metabolites during cold storage and reperfusion of isolated perfused rat kidneys. J Pharmacol Exp Ther (1998) 0.86
Trimetazidine for prevention of hepatic injury induced by ischaemia and reperfusion in rats. Eur J Surg (1993) 0.86
Liver injury following normothermic ischemia in steatotic rat liver. Hepatology (1994) 0.84
Strategies to modulate the deleterious effects of endothelin in hepatic ischemia-reperfusion. Transplantation (2000) 0.84
Trimetazidine ameliorates the hepatic injury associated with ischaemia-reperfusion in rats. Pharmacol Res (1999) 0.81
Improvement of rat liver graft quality by pifithrin-alpha-mediated inhibition of hepatocyte necrapoptosis. Hepatology (2004) 0.81
The impact of extended preservation on clinical liver transplantation. Transplantation (1990) 0.80
Effects of trimetazidine on ischemic contracture in isolated perfused rat hearts. J Cardiovasc Pharmacol (1994) 0.80
Trimetazidine effects on the damage to mitochondrial functions caused by ischemia and reperfusion. Am J Cardiol (1995) 0.80
Effects of taurine on liver preservation in UW solution with consecutive ischemic rewarming in the isolated perfused rat liver. Transpl Int (1995) 0.79
Pharmacological limitation of damage to renal medulla after cold storage and transplantation by trimetazidine. J Pharmacol Exp Ther (2000) 0.79
Definition of maximum cold ischemia time without reduction of graft quality in clinical liver transplantation. Transplant Proc (1998) 0.79
Effects of duration of ischemia and donor pretreatment with methylprednisolone or its macromolecular prodrug on the disposition of indocyanine green in cold-preserved rat livers. Pharm Res (2004) 0.79
Beneficial effect of pentoxifylline on microvesicular steatotic livers submitted to a prolonged cold ischemia. Transplantation (2003) 0.78
Use of isolated perfused rat liver model for testing liver preservation solutions. Transplant Proc (2001) 0.78
Effect of cadmium on bromosulfophthalein kinetics in the isolated perfused rat liver system. Toxicol Sci (2002) 0.78
Biliary complications in 400 cases of liver transplantation. Mt Sinai J Med (1994) 0.77
Sulfobromophthalein metabolism in isolated perfused rat liver. Factors determining the applicability of the model. Acta Physiol Lat Am (1979) 0.76
The effect of trimetazidine on liver regeneration after partial hepatectomy under hepatic blood inflow occlusion. Hepatogastroenterology (2003) 0.76
Trimetazidine improves recovery during reperfusion in isolated rat hearts after prolonged ischemia. Anadolu Kardiyol Derg (2003) 0.76
Endonuclease G is a novel determinant of cardiac hypertrophy and mitochondrial function. Nature (2011) 1.98
Effect of Lactobacillus johnsonii La1 and antioxidants on intestinal flora and bacterial translocation in rats with experimental cirrhosis. J Hepatol (2002) 1.69
New preservation strategies for preventing liver grafts against cold ischemia reperfusion injury. J Gastroenterol Hepatol (2007) 1.58
Preconditioning protects liver and lung damage in rat liver transplantation: role of xanthine/xanthine oxidase. Hepatology (2002) 1.54
Protection against lung damage in reduced-size liver transplantation. Crit Care Med (2006) 1.43
Carbonic Anhydrase Protects Fatty Liver Grafts against Ischemic Reperfusion Damage. PLoS One (2015) 1.36
Ischemic preconditioning increases the tolerance of Fatty liver to hepatic ischemia-reperfusion injury in the rat. Am J Pathol (2002) 1.32
Microvascular dysfunction induced by reperfusion injury and protective effect of ischemic preconditioning. Free Radic Biol Med (2002) 1.15
Ischemic preconditioning affects interleukin release in fatty livers of rats undergoing ischemia/reperfusion. Hepatology (2004) 1.11
Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation. Life Sci (2006) 1.08
Association of arterial rigidity with incident kidney disease and kidney function decline: the Health ABC study. Clin J Am Soc Nephrol (2012) 1.02
Intestinal mucosal oxidative damage and bacterial translocation in cirrhotic rats. Eur J Gastroenterol Hepatol (2003) 0.99
Silent cerebral white matter lesions and their relationship with vascular risk factors in middle-aged predialysis patients with CKD. Am J Kidney Dis (2006) 0.99
AMPK involvement in endoplasmic reticulum stress and autophagy modulation after fatty liver graft preservation: a role for melatonin and trimetazidine cocktail. J Pineal Res (2013) 0.98
Hypoxia inducible factor-1alpha accumulation in steatotic liver preservation: role of nitric oxide. World J Gastroenterol (2010) 0.97
Nitric oxide in ascitic fluid is an independent predictor of the development of renal impairment in patients with cirrhosis and spontaneous bacterial peritonitis. Eur J Gastroenterol Hepatol (2004) 0.97
Addition of adenosine monophosphate-activated protein kinase activators to University of Wisconsin solution: a way of protecting rat steatotic livers. Liver Transpl (2007) 0.96
Preservation of steatotic livers in IGL-1 solution. Liver Transpl (2006) 0.95
Pharmacological strategies against cold ischemia reperfusion injury. Expert Opin Pharmacother (2010) 0.92
Heat shock proteins and mitogen-activated protein kinases in steatotic livers undergoing ischemia-reperfusion: some answers. Am J Pathol (2006) 0.92
Adenosine monophosphate-activated protein kinase and nitric oxide in rat steatotic liver transplantation. J Hepatol (2005) 0.91
Phosphofructo-1-kinase deficiency leads to a severe cardiac and hematological disorder in addition to skeletal muscle glycogenosis. PLoS Genet (2009) 0.90
Hepatic microcirculatory failure. Acta Cir Bras (2006) 0.90
Is ischemic preconditioning a useful strategy in steatotic liver transplantation? Am J Transplant (2004) 0.89
Are angiotensin II receptor antagonists useful strategies in steatotic and nonsteatotic livers in conditions of partial hepatectomy under ischemia-reperfusion? J Pharmacol Exp Ther (2008) 0.89
Activation of peroxisome proliferator-activated receptor-alpha inhibits the injurious effects of adiponectin in rat steatotic liver undergoing ischemia-reperfusion. Hepatology (2008) 0.89
Exercise blood pressure, cardiac structure, and diastolic function in young normotensive patients with polycystic kidney disease: a prehypertensive state. Am J Kidney Dis (2004) 0.89
Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers. Hepatology (2003) 0.88
The combination of ischemic preconditioning and liver Bcl-2 overexpression is a suitable strategy to prevent liver and lung damage after hepatic ischemia-reperfusion. Am J Pathol (2002) 0.88
Addition of carvedilol to University Wisconsin solution improves rat steatotic and nonsteatotic liver preservation. Liver Transpl (2010) 0.87
Prevention of I/R injury in fatty livers by ischemic preconditioning is associated with increased mitochondrial tolerance: the key role of ATPsynthase and mitochondrial permeability transition. Transpl Int (2009) 0.87
Proteasome inhibitors protect the steatotic and non-steatotic liver graft against cold ischemia reperfusion injury. Exp Mol Pathol (2013) 0.86
Silent information regulator 1 protects the liver against ischemia-reperfusion injury: implications in steatotic liver ischemic preconditioning. Transpl Int (2014) 0.85
How to protect liver graft with nitric oxide. World J Gastroenterol (2011) 0.85
HIV-1 upregulates intercellular adhesion molecule-1 gene expression in lymphoid tissue of patients with chronic HIV-1 infection. J Acquir Immune Defic Syndr (2007) 0.84
Insulin like growth factor-1 increases fatty liver preservation in IGL-1 solution. World J Gastroenterol (2010) 0.84
The future of fatty livers. J Hepatol (2004) 0.84
Bortezomib enhances fatty liver preservation in Institut George Lopez-1 solution through adenosine monophosphate activated protein kinase and Akt/mTOR pathways. J Pharm Pharmacol (2013) 0.83
Inhibition of angiotensin II action protects rat steatotic livers against ischemia-reperfusion injury. Crit Care Med (2008) 0.83
Role of changes in tissular nucleotides on the development of apoptosis during ischemia/reperfusion in rat small bowel. Am J Pathol (2002) 0.82
Effect of angiotensin II and bradykinin inhibition in rat reduced-size liver transplantation. Liver Transpl (2009) 0.82
The Association between Parathyroid Hormone Levels and Hemoglobin in Diabetic and Nondiabetic Participants in the National Kidney Foundation's Kidney Early Evaluation Program. Cardiorenal Med (2013) 0.82
Ubiquitin-proteasome system inhibitors and AMPK regulation in hepatic cold ischaemia and reperfusion injury: possible mechanisms. Clin Sci (Lond) (2012) 0.81
Effects of trimetazidine on the Akt/eNOS signaling pathway and oxidative stress in an in vivo rat model of renal ischemia-reperfusion. Ren Fail (2014) 0.81
The effects of glucose and lipids in steatotic and non-steatotic livers in conditions of partial hepatectomy under ischaemia-reperfusion. Liver Int (2013) 0.81
Fructose-1,6-biphosphate and nucleoside pool modifications prevent neutrophil accumulation in the reperfused intestine. J Leukoc Biol (2003) 0.81
Streptozotocin-pancreatic damage in the rat: modulatory effect of 15-deoxy delta12,14-prostaglandin j(2) on nitridergic and prostanoid pathway. Nitric Oxide (2002) 0.80
Cyclic adenosine 3',5'-monophosphate in rat steatotic liver transplantation. Liver Transpl (2011) 0.80
Improved rat steatotic and nonsteatotic liver preservation by the addition of epidermal growth factor and insulin-like growth factor-I to University of Wisconsin solution. Liver Transpl (2010) 0.80
Melatonin prolongs graft survival of pancreas allotransplants in pigs. J Pineal Res (2011) 0.80
Up regulation of IL-6 by ischemic preconditioning in normal and fatty rat livers: association with reduction of oxidative stress. Free Radic Res (2006) 0.80
Insulin-like growth factor and epidermal growth factor treatment: new approaches to protecting steatotic livers against ischemia-reperfusion injury. Endocrinology (2009) 0.80
Adiponectin and resistin protect steatotic livers undergoing transplantation. J Hepatol (2013) 0.80
Characterisation of Lafora-like bodies and other polyglucosan bodies in two aged dogs with neurological disease. Vet J (2008) 0.79
Mediators of rat ischemic hepatic preconditioning after cold preservation identified by microarray analysis. Liver Transpl (2006) 0.79
Simvastatin maintains function and viability of steatotic rat livers procured for transplantation. J Hepatol (2013) 0.79
Does adiponectin benefit steatotic liver transplantation? Liver Transpl (2011) 0.79
Rifaximin, but not growth factor 1, reduces brain edema in cirrhotic rats. World J Gastroenterol (2012) 0.78
Retinol-binding protein 4 and peroxisome proliferator-activated receptor-γ in steatotic liver transplantation. J Pharmacol Exp Ther (2011) 0.78
Rat CCl(4)-induced cirrhosis plus total portal vein ligation: a new model for the study of hyperammonaemia and brain oedema. Liver Int (2010) 0.77
Evaluation of Institut Georges Lopez-1 preservation solution in pig pancreas transplantation: a pilot study. Transplantation (2014) 0.76
Retinol binding protein 4 and retinol in steatotic and nonsteatotic rat livers in the setting of partial hepatectomy under ischemia/reperfusion. Liver Transpl (2012) 0.76
Role of oxidative stress in cardiovascular effects of anemia treatment with erythropoietin in predialysis patients with chronic kidney disease. Clin Nephrol (2012) 0.76
The use of a reversible proteasome inhibitor in a model of Reduced-Size Orthotopic Liver transplantation in rats. Exp Mol Pathol (2012) 0.76
Correction: Carbonic Anhydrase Protects Fatty Liver Grafts against Ischemic Reperfusion Damage. PLoS One (2015) 0.75
Protective effects of exogenous fructose-1,6-biphosphate during small bowel transplantation in rats. Surgery (2004) 0.75